Sonoma Pharmaceuticals (SNOA) EPS (Basic) Growth (3y) (2013 - 2026)
Sonoma Pharmaceuticals (SNOA) EPS (Basic) Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 50.53% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 6.20% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -70.04% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 6.69% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -6.51% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 65.05% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -18.26% |
| 10 | Sonoma Pharmaceuticals | 179.80 | -2.40 Mn | 2.18 Mn | 96.45% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 96.45% |
| Dec 31, 2025 | 96.63% |
| Sep 30, 2025 | 96.33% |
| Jun 30, 2025 | 49.06% |
| Sep 30, 2024 | 11.57% |
| Jun 30, 2024 | 49.61% |
| Mar 31, 2024 | -0.91% |
| Dec 31, 2023 | -89.34% |
| Sep 30, 2023 | -2,550.91% |
| Jun 30, 2023 | -723.39% |
| Mar 31, 2023 | -3,422.59% |
| Dec 31, 2022 | -1,852.92% |
| Sep 30, 2022 | -1,619.62% |
| Jun 30, 2022 | -123.61% |
| Sep 30, 2021 | 77.28% |
| Jun 30, 2021 | 53.02% |
| Mar 31, 2020 | -79.69% |
| Dec 31, 2019 | -86.34% |
| Sep 30, 2019 | -64.78% |
| Jun 30, 2019 | -97.15% |